Microfluidic Leukocyte Stretching for High-Throughput Deformability Testing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring cell deformability suffer from low throughput and inconsistent results, limiting their clinical impact and translational use, particularly in applications requiring large sample sizes and accurate detection of rare cell abnormalities.
Innovation Solution
A microfluidic device utilizing intersecting flows to create an extensional region for controlled cell stretching, combined with high-speed imaging and automated analysis, enabling the measurement of cellular mechanical parameters at over 1,000 cells per second.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If single-cell platforms (AFM, optical stretching) are used to measure cell deformability, then measurement precision is improved, but productivity deteriorates to around 1 cell/minute
Solution Approach 1:
The patent segments the measurement process into independent parallel channels, with each channel measuring one cell at a time. Multiple channels operate simultaneously to achieve high throughput while maintaining single-cell measurement precision. The device includes arrays of micropipettes or microfluidic channels that process cells in parallel rather than sequentially.
Solution Approach 2:
The patent replaces manual or slow mechanical measurement systems (AFM, optical stretching) with an automated microfluidic system that uses controlled fluid flow to deform cells. This substitution enables automated, high-speed deformation and measurement without requiring manual operation or complex optical setups for each cell.
2Productivity
If bulk platforms (microfiltration) are used to measure cell deformability, then productivity is improved with high throughput, but measurement precision deteriorates by yielding only one endpoint measurement that misses heterogeneity
Solution Approach 1:
The patent divides the bulk sample into individual cell measurements across multiple parallel channels. Each channel provides an independent measurement, allowing detection of rare abnormalities while maintaining high overall throughput. The segmentation enables both single-cell resolution and population-level statistics.
Solution Approach 2:
The patent performs preliminary focusing of cells into streamlines before they enter the measurement region. This preliminary action ensures that cells are properly positioned and oriented for accurate measurement, enabling precise detection of individual cell properties while maintaining high throughput.
3Measurement precision
If current single-cell platforms are used, then measurement precision is improved, but loss of time increases due to low throughput requiring large sample sizes for statistical significance
Solution Approach 1:
The patent implements continuous flow of cells through the measurement device, with cells being constantly deformed and measured as they flow through the microfluidic channels. This continuous operation eliminates idle time between measurements and enables rapid accumulation of statistically significant data from large numbers of cells.
Solution Approach 2:
The patent uses multiple parallel measurement channels that operate simultaneously, allowing many cells to be measured in parallel rather than sequentially. This segmentation of the measurement process dramatically reduces the total time required to obtain statistically significant results while maintaining single-cell measurement precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system provides high-throughput, label-free cell deformability measurements, reducing costs and labor, and enabling accurate identification of cell sub-populations and biomarkers for clinical and research applications.
Implementation Method 1
The microfluidic device uses intersecting flows to create an extensional flow region where the cells undergo controlled stretching
Implementation Method 2
Each cell's deformation is measured with an imaging device
Data Source
AI summary
A system is disclosed that enables the automated measurement of cellular mechanical parameters at high throughputs. The microfluidic device uses intersecting flows to create an extensional flow region where the cells undergo controlled stretching. Cells are focused into streamlines prior to entering the extensional flow region. In the extensional region, each cell's deformation is measured with an imaging device. Automated image analysis extracts a range of independent biomechanical parameters from the images. These may include cell size, deformability, and circularity. The single cell data that is obtained may then be used to in a variety of ways. Scatter density plots of deformability and circularity may be developed and displayed for the user. Mechanical parameters such as deformability and circularity may be gated or thresholded to identify certain cells of interest or sub-populations of interest. Similarly, the mechanical data obtained using the device may be used as cell signatures.